Whole-genome characterization of chemoresistant ovarian cancer (Q50272478)

28 February 2018

title

Whole-genome characterization of chemoresistant ovarian cancer (English)

1 reference

28 February 2018

1 reference

whole genome sequencing

1 reference

Erratum: Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer

inferred from title

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NATURE15716

author

Richard W. Tothill

44

1 reference

28 February 2018

Angelika N Christ

53

1 reference

28 February 2018

Ronny Drapkin

65

1 reference

28 February 2018

Ravikiran Vedururu

76

1 reference

28 February 2018

Sean Grimmond

82

1 reference

28 February 2018

Dale W Garsed

Dale W Garsed

4

0 references

Elizabeth L Christie

Elizabeth L Christie

2

0 references

Jason Ellul

Jason Ellul

73

0 references

Gisela Mir Arnau

Gisela Mir Arnau

43

0 references

Peter J Bailey

Peter J Bailey

10

0 references

Kathryn Alsop

Kathryn Alsop

Charlotte S Wilhelm-Benartzi

9

0 references

Charlotte Wilhelm-Benartzi

16

0 references

Paul Harnett

Paul Harnett

26

0 references

Anna deFazio

Anna deFazio

81

0 references

Heather Thorne

Heather Thorne

40

0 references

Nicola J Waddell

Nicola Waddell

80

0 references

Ernst Lengyel

Ernst Lengyel

Australian Ovarian Cancer Study Group

78

0 references

19

Australian Ovarian Cancer Study Group

1 reference

28 February 2018

83

David D L Bowtell

1 reference

28 February 2018

13

Michael C J Quinn

1 reference

28 February 2018

Prue A Cowin

8

Prue Cowin

1 reference

28 February 2018

Dariush Etemadmoghadam

3

Dariush Etemadmoghadam

1 reference

28 February 2018

Yoke-Eng Chiew

25

Yoke-Eng Chiew

1 reference

28 February 2018

Euan A Stronach

66

Euan Stronach

1 reference

28 February 2018

Sian Fereday

6

Sian Fereday

1 reference

28 February 2018

Jillian Hung

24

Jillian Hung

1 reference

28 February 2018

Nadia Traficante

38

Nadia Traficante

1 reference

28 February 2018

George Au-Yeung

22

George Au-Yeung

1 reference

28 February 2018

Joy Hendley

39

Joy Hendley

1 reference

28 February 2018

Orla M McNally

74

Orla McNally

1 reference

28 February 2018

Linda Mileshkin

21

Linda Mileshkin

1 reference

28 February 2018

Timothy Semple

46

Timothy Semple

1 reference

28 February 2018

Ann-Marie Patch

1

Ann-Marie Patch

1 reference

28 February 2018

Walid J Azar

36

Walid Azar

1 reference

28 February 2018

David K Miller

42

David K Miller

1 reference

28 February 2018

author name string

Joshy George

5

1 reference

28 February 2018

Katia Nones

7

1 reference

28 February 2018

Karin S Kassahn

11

1 reference

28 February 2018

Felicity Newell

12

1 reference

28 February 2018

Stephen Kazakoff

14

1 reference

28 February 2018

Kelly Quek

15

1 reference

28 February 2018

Ed Curry

17

1 reference

28 February 2018

Huei San Leong

18

1 reference

28 February 2018

Anne Hamilton

20

1 reference

28 February 2018

Catherine Kennedy

23

1 reference

28 February 2018

Michael Friedlander

27

1 reference

28 February 2018

Michael Quinn

28

1 reference

28 February 2018

Jan Pyman

29

1 reference

28 February 2018

Stephen Cordner

30

1 reference

28 February 2018

Patricia O'Brien

31

1 reference

28 February 2018

Jodie Leditschke

32

1 reference

28 February 2018

Greg Young

33

1 reference

28 February 2018

Kate Strachan

34

1 reference

28 February 2018

Paul Waring

35

1 reference

28 February 2018

Chris Mitchell

37

1 reference

28 February 2018

Mark Shackleton

41

1 reference

28 February 2018

Timothy P Holloway

45

1 reference

28 February 2018

Ivon Harliwong

47

1 reference

28 February 2018

Craig Nourse

48

1 reference

28 February 2018

Ehsan Nourbakhsh

49

1 reference

28 February 2018

Suzanne Manning

50

1 reference

28 February 2018

Senel Idrisoglu

51

1 reference

28 February 2018

Timothy J C Bruxner

52

1 reference

28 February 2018

Barsha Poudel

54

1 reference

28 February 2018

Oliver Holmes

55

1 reference

28 February 2018

Matthew Anderson

56

1 reference

28 February 2018

Conrad Leonard

57

1 reference

28 February 2018

Andrew Lonie

58

1 reference

28 February 2018

Nathan Hall

59

1 reference

28 February 2018

Scott Wood

60

1 reference

28 February 2018

Darrin F Taylor

61

1 reference

28 February 2018

Qinying Xu

62

1 reference

28 February 2018

J Lynn Fink

63

1 reference

28 February 2018

Nick Waddell

64

1 reference

28 February 2018

Hani Gabra

67

1 reference

28 February 2018

Robert Brown

68

1 reference

28 February 2018

Andrea Jewell

69

1 reference

28 February 2018

Shivashankar H Nagaraj

70

1 reference

28 February 2018

Emma Markham

71

1 reference

28 February 2018

Peter J Wilson

72

1 reference

28 February 2018

Maria A Doyle

75

1 reference

28 February 2018

Collin Stewart

77

1 reference

28 February 2018

John V Pearson

79

1 reference

28 February 2018

language of work or name

English

0 references

publication date

1 May 2015

1 reference

28 February 2018

published in

Nature

1 reference

28 February 2018

volume

521

1 reference

28 February 2018

issue

7553

1 reference

28 February 2018

page(s)

489-494

1 reference

28 February 2018

Rethinking ovarian cancer: recommendations for improving outcomes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Emerging landscape of oncogenic signatures across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Combinatorics of the breakage-fusion-bridge mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Punctuated evolution of prostate cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Ovarian cancer development and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Resistance to therapy caused by intragenic deletion in BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Discovery and saturation analysis of cancer genes across 21 tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Fast and accurate short read alignment with Burrows-Wheeler transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

RNA-SeQC: RNA-seq metrics for quality control and process optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

MapSplice: accurate mapping of RNA-seq reads for splice junction discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Review of processing and analysis methods for DNA methylation array data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Adjusting batch effects in microarray expression data using empirical Bayes methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Somatic point mutation calling in low cellularity tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

IntOGen: integration and data mining of multidimensional oncogenomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Integrative genomics viewer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Landscape of genomic alterations in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Mutational processes molding the genomes of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Criteria for inference of chromothripsis in cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14410

Frequency of BRCA1 dysfunction in ovarian cancer

21 January 2018

1 reference

12 December 2020

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease

1 reference

12 December 2020

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

1 reference

12 December 2020

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss

1 reference

12 December 2020

Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE14410

1 reference

28 February 2018

1 reference

28 February 2018